Acts Online
GT Shield

Mine Health and Safety Act, 1996 (Act No. 29 of 1996)

Notices

Guidance Note for a Management and Control Programme for Tuberculosis in the South African Mining Industry

Part B : Author's Guide

8. Case monitoring

 

8.1 Smear positive patients should be kept isolated in the ward where possible, until they are smear negative.

 

8.2 A holistic package of TB care should include: HCT; adherence counselling; psychological support; nutritional assessment and education; and integration with the HIV prevention and management programme.

 

8.3 A treatment adherence programme should be implemented for all TB cases. The programme should cover the following:
8.3.1 Education about the disease;
8.3.2 Duration of treatment;

8.3.3        Medication to be taken and possible side effects;

8.3.4        Importance of adherence to prescribed treatment regime;

8.3.5        Psychological support when required; and

8.3.6        Treatment support and monitoring.

 

8.4 The response to treatment should be assessed at the end of the intensive and continuation treatment phases in accordance with the NTBMG.

 

8.5 For assessment and reporting of possible disability, a clinical examination, chest-x-ray and lung function test should be performed six to twelve months after completion of therapy.

 

8.6 Leave arrangements for employees on TB treatment should take account of the following:
8.6.1 Taking leave during the initial phase of treatment is not encouraged.
8.6.2 When leave is taken, there must be counselling and provision of sufficient medication.